Salarius Pharmaceuticals, Inc.·4

May 31, 5:13 PM ET

Rosenblum Mark J 4

4 · Salarius Pharmaceuticals, Inc. · Filed May 31, 2022

Insider Transaction Report

Form 4
Period: 2022-05-31
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
  • Purchase

    Common Stock

    2022-05-31$0.18/sh+28,000$5,040148,319 total

Documents

1 file
  • 4
    wf-form4_165403159108429.xmlPrimary

    FORM 4